SBLOF (Shin Nippon Biomedical Laboratories) Quick Ratio: 0.71 (As of Mar. 2026) — Near Median


SBLOF Shin Nippon Biomedical Laboratories Ltd SBLOF
77 GF Score
Price $9.16
GF Value $14.46
! 5 Warning Signs
View Full Analysis

What is Shin Nippon Biomedical Laboratories Quick Ratio?

Shin Nippon Biomedical Laboratories SBLOF -2.13% 77 Quick Ratio is 0.71 as of Mar. 2026, which is 1% above its 10-year median of 0.70. GuruFocus rates SBLOF with a GF Score™ of 77/100 and a GF Value™ of $14.46. The stock has 5 warning signs investors should review. Among 214 Medical Diagnostics & Research companies, Shin Nippon Biomedical Laboratories ranks worse than 82.24% on this metric.

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Shin Nippon Biomedical Laboratories's quick ratio for the quarter that ended in Mar. 2026 was 0.71.

Shin Nippon Biomedical Laboratories has a quick ratio of 0.71. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for Shin Nippon Biomedical Laboratories's Quick Ratio or its related term are showing as below:

SBLOF' s Quick Ratio Range Over the Past 10 Years
Min: 0.43   Med: 0.7   Max: 0.9
Current: 0.71

During the past 13 years, Shin Nippon Biomedical Laboratories's highest Quick Ratio was 0.90. The lowest was 0.43. And the median was 0.70.

SBLOF's Quick Ratio is ranked worse than
82.24% of 214 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.69 vs SBLOF: 0.71

Shin Nippon Biomedical Laboratories  (OTCPK:SBLOF) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Shin Nippon Biomedical Laboratories Quick Ratio Related Terms


Shin Nippon Biomedical Laboratories Quick Ratio Historical Data

* Premium members only.

The historical data trend for Shin Nippon Biomedical Laboratories's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shin Nippon Biomedical Laboratories Quick Ratio Chart

Shin Nippon Biomedical Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.88 0.79 0.78 0.69 0.71

Shin Nippon Biomedical Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.69 0.70 0.66 0.63 0.71

SBLOF vs TMO, DHR, IDXX: Quick Ratio Comparison

For the Diagnostics & Research subindustry, Shin Nippon Biomedical Laboratories's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shin Nippon Biomedical Laboratories Quick Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Shin Nippon Biomedical Laboratories's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Shin Nippon Biomedical Laboratories's Quick Ratio falls into.


SBLOF
77GF Score
Shin Nippon Biomedical Laboratories Ltd SBLOF
Quick Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shin Nippon Biomedical Laboratories Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Shin Nippon Biomedical Laboratories's Quick Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Quick Ratio (A: Mar. 2026 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(270.91-95.247)/247.824
=0.71

Shin Nippon Biomedical Laboratories's Quick Ratio for the quarter that ended in Mar. 2026 is calculated as

Quick Ratio (Q: Mar. 2026 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(270.91-95.247)/247.824
=0.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Quick Ratio →
What does a Quick Ratio of 0.71 mean?
Shin Nippon Biomedical Laboratories (SBLOF) has a Quick Ratio of 0.71 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Shin Nippon Biomedical Laboratories and its competitors. This is near median its historical median of 0.70. Over the past decade, Shin Nippon Biomedical Laboratories' Quick Ratio has ranged from 0.43 to 0.90. According to the industry distribution chart, Shin Nippon Biomedical Laboratories ranks #176 out of 214 companies in the Medical Diagnostics & Research industry, placing it in the top 82.2%.
Is Shin Nippon Biomedical Laboratories' Quick Ratio too high?
Shin Nippon Biomedical Laboratories' current Quick Ratio of 0.71 is near median its 10-year median of 0.70. Over the past 10 years, this metric has ranged from a low of 0.43 to a high of 0.90. The Medical Diagnostics & Research industry median Quick Ratio is 1.69. Shin Nippon Biomedical Laboratories' value of 0.71 is 58% below this industry median. Based on the distribution chart, Shin Nippon Biomedical Laboratories ranks #176 out of 214 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Shin Nippon Biomedical Laboratories has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Shin Nippon Biomedical Laboratories' Quick Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Shin Nippon Biomedical Laboratories ranks #176 out of 214 companies for Quick Ratio. This places Shin Nippon Biomedical Laboratories in the lower half of its industry. The industry median Quick Ratio is 1.69. Shin Nippon Biomedical Laboratories' value of 0.71 is 58% below this benchmark. Historically, Shin Nippon Biomedical Laboratories' own Quick Ratio has ranged from 0.43 to 0.90 over the past decade. While the company's 10-year median is 0.70 vs. the industry median of 1.69, Shin Nippon Biomedical Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Diagnostics & Research company?
The median Quick Ratio among Medical Diagnostics & Research companies is 1.69, based on 214 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shin Nippon Biomedical Laboratories's current Quick Ratio of 0.71 is 58% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Shin Nippon Biomedical Laboratories and its competitors. For the Medical Diagnostics & Research industry, the median Quick Ratio is 1.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shin Nippon Biomedical Laboratories's current Quick Ratio is 0.71, which is near median its own 10-year median of 0.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shin Nippon Biomedical Laboratories stock overvalued right now?
Shin Nippon Biomedical Laboratories (SBLOF) has a current Quick Ratio of 0.71. The stock's GF Value™ is $14.46, compared to a current price of $9.16 — trading 36.6% below its estimated fair value. The current Quick Ratio is 0.71, which is near median its 10-year median of 0.70 and 58% below the Medical Diagnostics & Research industry median of 1.69. Shin Nippon Biomedical Laboratories' overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Shin Nippon Biomedical Laboratories (SBLOF), the current Quick Ratio is 0.71 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shin Nippon Biomedical Laboratories (SBLOF) Overvalued in 2026?

Based on GuruFocus' analysis, Shin Nippon Biomedical Laboratories stock appears to be undervalued. The current stock price of $9.16 is trading 36.6% below its estimated GF Value™ of $14.46.

Key valuation signals for SBLOF:

  • Quick Ratio: 0.71 (near median its 10-year median of 0.70)
  • GF Value™: $14.46 vs. price of $9.16 (36.6% below fair value)
  • GF Score™: 77/100 with 5 warning signs
  • Industry Position: 58% below the Medical Diagnostics & Research median (#176 of 214)

No single metric tells the full story. See the SBLOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shin Nippon Biomedical Laboratories Business Description

Other Exchanges 2395:JapanYB3:Germany
Address 8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
77GF Score

Get the complete analysis for SBLOF

Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.16
Price
$14.46
GF Value